Peptide Atlas · Vitamin

Riboflavin

In a three-month randomized trial in 55 people with migraine, high-dose riboflavin (400 mg a day) reduced attack frequency and headache days more than placebo, with 59% responders against 15%.

emerging

provisional
PubChem 493570
2 citations
0 discussions
0 followers
7,8-dimethyl-10-ribitylisoalloxazine
Lactoflavin
Vitamin B2
Vitamin G

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Riboflavin. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
High-dose riboflavin for migraine prophylaxis (RCT, n=55)	emerging	pmid 9484373
Riboflavin-UVA cross-linking increases corneal rigidity (ex vivo)	preclinical	pmid 14522301

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.